162 related articles for article (PubMed ID: 24509250)
41. A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.
Anosova NG; Cole LE; Li L; Zhang J; Brown AM; Mundle S; Zhang J; Ray S; Ma F; Garrone P; Bertraminelli N; Kleanthous H; Anderson SF
Clin Vaccine Immunol; 2015 Jul; 22(7):711-25. PubMed ID: 25924765
[TBL] [Abstract][Full Text] [Related]
42. Effect of biotherapeutics on antitoxin IgG in experimentally induced Clostridium difficile infection.
Kaur S; Vaishnavi C; Kochhar R; Prasad KK; Ray P
Indian J Med Microbiol; 2012; 30(4):431-6. PubMed ID: 23183468
[TBL] [Abstract][Full Text] [Related]
43. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
Kyne L; Warny M; Qamar A; Kelly CP
N Engl J Med; 2000 Feb; 342(6):390-7. PubMed ID: 10666429
[TBL] [Abstract][Full Text] [Related]
44. Active and passive immunization against Clostridium difficile diarrhea and colitis.
Giannasca PJ; Warny M
Vaccine; 2004 Feb; 22(7):848-56. PubMed ID: 15040937
[TBL] [Abstract][Full Text] [Related]
45. Epithelium-specific MyD88 signaling, but not DCs or macrophages, control acute intestinal infection with Clostridium difficile.
Mamareli P; Kruse F; Friedrich C; Smit N; Strowig T; Sparwasser T; Lochner M
Eur J Immunol; 2019 May; 49(5):747-757. PubMed ID: 30802297
[TBL] [Abstract][Full Text] [Related]
46. Immune responses induced by Clostridium difficile.
Péchiné S; Collignon A
Anaerobe; 2016 Oct; 41():68-78. PubMed ID: 27108093
[TBL] [Abstract][Full Text] [Related]
47. Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis.
Mahida YR; Galvin A; Makh S; Hyde S; Sanfilippo L; Borriello SP; Sewell HF
Infect Immun; 1998 Nov; 66(11):5462-9. PubMed ID: 9784558
[TBL] [Abstract][Full Text] [Related]
48. The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.
Hansen A; Alston L; Tulk SE; Schenck LP; Grassie ME; Alhassan BF; Veermalla AT; Al-Bashir S; Gendron FP; Altier C; MacDonald JA; Beck PL; Hirota SA
PLoS One; 2013; 8(11):e81491. PubMed ID: 24278446
[TBL] [Abstract][Full Text] [Related]
49. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin.
Leung DY; Kelly CP; Boguniewicz M; Pothoulakis C; LaMont JT; Flores A
J Pediatr; 1991 Apr; 118(4 Pt 1):633-7. PubMed ID: 1901084
[TBL] [Abstract][Full Text] [Related]
50. NF-kappa B activation pathway is essential for the chemokine expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A.
Kim JM; Lee JY; Yoon YM; Oh YK; Youn J; Kim YJ
Scand J Immunol; 2006 Jun; 63(6):453-60. PubMed ID: 16764699
[TBL] [Abstract][Full Text] [Related]
51. The Insect Peptide CopA3 Increases Colonic Epithelial Cell Proliferation and Mucosal Barrier Function to Prevent Inflammatory Responses in the Gut.
Kim DH; Hwang JS; Lee IH; Nam ST; Hong J; Zhang P; Lu LF; Lee J; Seok H; Pothoulakis C; Lamont JT; Kim H
J Biol Chem; 2016 Feb; 291(7):3209-23. PubMed ID: 26655716
[TBL] [Abstract][Full Text] [Related]
52. Correlation of the detection of Clostridium difficile toxins in stools and presence of the clostridia in tissues of children.
Guarner J; Bhatnagar J; Shane AL; Jones T; DeLeon-Carnes MN; Schemankewitz E; Zaki SR
Hum Pathol; 2010 Nov; 41(11):1586-92. PubMed ID: 20656321
[TBL] [Abstract][Full Text] [Related]
53. The American cockroach peptide periplanetasin-4 inhibits Clostridium difficile toxin A-induced cell toxicities and inflammatory responses in the mouse gut.
Yoon IN; Lu LF; Hong J; Zhang P; Kim DH; Kang JK; Hwang JS; Kim H
J Pept Sci; 2017 Nov; 23(11):833-839. PubMed ID: 28949065
[TBL] [Abstract][Full Text] [Related]
54. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
Torres JF; Monath TP
J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
[TBL] [Abstract][Full Text] [Related]
55. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
56. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers.
Stubbe H; Berdoz J; Kraehenbuhl JP; Corthésy B
J Immunol; 2000 Feb; 164(4):1952-60. PubMed ID: 10657645
[TBL] [Abstract][Full Text] [Related]
57. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
58. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.
Kink JA; Williams JA
Infect Immun; 1998 May; 66(5):2018-25. PubMed ID: 9573084
[TBL] [Abstract][Full Text] [Related]
59. Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea.
Bacon AE; Fekety R
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):205-9. PubMed ID: 7924215
[TBL] [Abstract][Full Text] [Related]
60. Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells.
Castagliuolo I; Keates AC; Wang CC; Pasha A; Valenick L; Kelly CP; Nikulasson ST; LaMont JT; Pothoulakis C
J Immunol; 1998 Jun; 160(12):6039-45. PubMed ID: 9637520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
